Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.3.2 added and v3.3.1 removed.
    Difference
    0.1%
    Check dated 2025-12-01T10:40:39.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision history updated to include v3.3.1 and remove v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T04:09:47.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page removed the government funding disclaimer about potential delays and the NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2025-11-16T16:25:30.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study record history shows only the initial version (2023-04-17) with no changes listed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T07:23:57.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Added a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.
    Difference
    13%
    Check dated 2025-10-04T16:57:17.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; core content and other critical elements remain unchanged.
    Difference
    0.3%
    Check dated 2025-09-27T13:40:04.000Z thumbnail image

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.